FDA Status Checker
Approval and compounding status for peptides in the US
FDA Status Checker
Approval and compounding status for peptides in the US
Semaglutide
GLP-1 Agonist
FDA Approved (Ozempic, Wegovy, Rybelsus)
Tirzepatide
Dual GIP/GLP-1 Agonist
FDA Approved (Mounjaro, Zepbound)
BPC-157
Regenerative / GI Protective
Not FDA Approved — Research Peptide
TB-500 (Thymosin Beta-4)
Regenerative / Anti-inflammatory
Not FDA Approved — Research Peptide
Ipamorelin
Growth Hormone Secretagogue
Not FDA Approved — Research Peptide
CJC-1295 / Ipamorelin
Growth Hormone Secretagogue
Not FDA Approved — Research Peptide
GHK-Cu (Copper Peptide)
Regenerative / Anti-Aging
Not FDA Approved — Research Peptide / Cosmetic Ingredient
Liraglutide
GLP-1 Agonist
FDA Approved (Victoza, Saxenda)
PT-141 (Bremelanotide)
Melanocortin Agonist
FDA Approved (Vyleesi) for hypoactive sexual desire disorder in premenopausal women
Selank
Nootropic / Anxiolytic
Not FDA Approved — Research Peptide